Mise au point sur les glioblastomes : des thérapies ciblant les cellules tumorales aux thérapies ciblant les cellules immunitaires

These data provide strong evidence to support the potential of associating combinatorial targeted and/or immunotherapeutic regimens in patients with GBM that may change patient outcome.